Randomized phase I trial HIV-CORE 003: Depletion of serum amyloid P component and immunogenicity of DNA vaccination against HIV-1
Fig 5
HLA-A*02:01/YQY tetramer-aided analysis of human CD8+ T-cell memory subsets.
For six HLA-A*02:01-positive vaccine recipients, frozen and thawed PBMCs from indicated time point were analyzed for memory subsets defined as TN−naïve T cells (CD45RAhiCCR7hiCD27hi). TCM—central memory (CD45RAloCCR7hiCD27hi), TTM—transitional memory (CD45RAloCCR7loCD27hi), TEM—effector memory (CD45RAloCCR7loCD27lo), and TTD—terminally differentiated (CD45RAhiCCR7loCD27lo). See S1 Fig for the gating strategy. D–pSG2.HIVconsv DNA; C–ChAdV63.HIVconsv; M–MVA.HIVconsv. The number next to the regimen indicates weeks after administration of the last vaccine.